Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAltintas F.
dc.contributor.authorGurbuz H.
dc.contributor.authorErdemli B.
dc.contributor.authorAtilla B.
dc.contributor.authorUstaoglu R.G.
dc.contributor.authorOzic U.
dc.contributor.authorKinik H.
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T15:53:33Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T15:53:33Z
dc.date.issued2008
dc.identifier.issn1017995X
dc.identifier.urihttps://dx.doi.org/10.3944/AOTT.2008.322
dc.identifier.urihttp://hdl.handle.net/11446/1962
dc.descriptionPubMed ID: 19158452en_US
dc.description.abstractObjectives: We investigated risk factors for venous thromboembolism (VTE), prophylaxis measures employed, and incidence of symptomatic deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing major orthopaedic surgery (MOS). Methods: An open, multicenter, prospective, observational study was conducted in 21 medical centers, comprising 899 patients. Of these, 316 patients (35.2%) underwent total hip arthroplasty (THA), 328 patients (36.5%) underwent total knee arthroplasty (TKA), and 255 patients (28.4%) underwent surgery for hip fractures (HF). Pharmacologic prophylaxis was employed in all the patients. Results: Risk factors for VTE were seen in 73.2% of the patents, the most common being obesity (72%) and prolonged immobilization (36.3%). Low-molecular-weight heparin (91.1%) and fondaparinux (8.9%) were used for prophylaxis, which was short-term in 273 patients (30.4%) and long-term in 626 patients (69.6%). Mechanical prophylaxis was performed with compression stockings in 610 patients (67.9%) and by intermittent pneumatic compression in 67 patients (7.5%). During three-months of follow-up, symptomatic DVT and PE were seen in eight (0.9%) and four patients (0.4%), respectively. Mortality occurred in 10 patients (1.1%). Complications of major and minor bleeding were seen in eight (0.9%) and 40 (4.5%) patients, respectively. Conclusion: Effective VTE prophylaxis is associated with low risk of clinically apparent DVT and PE in MOS. © 2008 Turkish Association of Orthopaedics and Traumatology.en_US
dc.language.isoturen_US
dc.identifier.doi10.3944/AOTT.2008.322en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnticoagulants/therapeutic useen_US
dc.subjectArthroplasty, replacement, hipen_US
dc.subjectArthroplasty, replacement, kneeen_US
dc.subjectPostoperative complicationsen_US
dc.subjectRisk factorsen_US
dc.subjectThromboembolismen_US
dc.subjectVenous thrombosisen_US
dc.titleVenous thromboembolism prophylaxis in major orthopaedic surgery: A multicenter, prospective, observational study [Majör ortopedik cerrahilerde venöz tromboemboli profilaksisi: Çokmerkezli, prospektif, gözlem çali{dotless}şmasi{dotless}]en_US
dc.typearticleen_US
dc.relation.journalActa Orthopaedica et Traumatologica Turcicaen_US
dc.departmentDBÜen_US
dc.identifier.issue5en_US
dc.identifier.volume42en_US
dc.identifier.startpage322en_US
dc.identifier.endpage327en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempDBÜen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster